1. Home
  2. HALO vs SRAD Comparison

HALO vs SRAD Comparison

Compare HALO & SRAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • SRAD
  • Stock Information
  • Founded
  • HALO 1998
  • SRAD 2001
  • Country
  • HALO United States
  • SRAD Switzerland
  • Employees
  • HALO N/A
  • SRAD N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • SRAD Computer Software: Programming Data Processing
  • Sector
  • HALO Health Care
  • SRAD Technology
  • Exchange
  • HALO Nasdaq
  • SRAD Nasdaq
  • Market Cap
  • HALO 9.0B
  • SRAD 9.0B
  • IPO Year
  • HALO N/A
  • SRAD 2021
  • Fundamental
  • Price
  • HALO $65.56
  • SRAD $25.42
  • Analyst Decision
  • HALO Buy
  • SRAD Strong Buy
  • Analyst Count
  • HALO 10
  • SRAD 17
  • Target Price
  • HALO $73.40
  • SRAD $30.59
  • AVG Volume (30 Days)
  • HALO 2.2M
  • SRAD 2.4M
  • Earning Date
  • HALO 10-30-2025
  • SRAD 11-06-2025
  • Dividend Yield
  • HALO N/A
  • SRAD N/A
  • EPS Growth
  • HALO 68.93
  • SRAD 359.43
  • EPS
  • HALO 4.37
  • SRAD 0.43
  • Revenue
  • HALO $1,178,672,000.00
  • SRAD $1,399,017,029.00
  • Revenue This Year
  • HALO $32.57
  • SRAD $19.11
  • Revenue Next Year
  • HALO $23.25
  • SRAD $16.92
  • P/E Ratio
  • HALO $15.12
  • SRAD $58.77
  • Revenue Growth
  • HALO 34.97
  • SRAD 19.37
  • 52 Week Low
  • HALO $42.01
  • SRAD $11.72
  • 52 Week High
  • HALO $79.50
  • SRAD $32.22
  • Technical
  • Relative Strength Index (RSI)
  • HALO 31.20
  • SRAD 25.19
  • Support Level
  • HALO $73.06
  • SRAD $25.91
  • Resistance Level
  • HALO $76.30
  • SRAD $27.40
  • Average True Range (ATR)
  • HALO 2.33
  • SRAD 0.99
  • MACD
  • HALO -1.57
  • SRAD -0.46
  • Stochastic Oscillator
  • HALO 3.81
  • SRAD 5.85

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About SRAD Sportradar Group AG

Sportradar Group AG is a technology platform enabling next-generation engagement in sports, and a provider of B2B solutions to the sports betting industry. It generates revenue through two primary sources: subscription-based revenue and revenue sharing. Geographically, it operates in North America, Africa, AsiaPac & Middle East, Europe, and LATAM & Caribbean.

Share on Social Networks: